Breaking News
Get 40% Off 0
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool. See stock ideas
Close

Marker Therapeutics Inc (MRKR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Marker Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.090 -0.110    -2.62%
- Closed. Currency in USD ( Disclaimer )
After Hours
4.110
+0.020
+0.489%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 7,673
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.090 - 4.380
Marker Therapeutics 4.090 -0.110 -2.62%

Marker Therapeutics Inc Company Profile

 
Get an in-depth profile of Marker Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

8

Equity Type

ORD

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Contact Information

Address 9350 Kirby Drive Suite 300
Houston, 77054
United States
Phone 713 400 6400
Fax -

Top Executives

Name Age Since Title
Malcolm K. Brenner 71 2018 Member of Scientific Advisory Board
Padmanee Sharma - 2018 Member of Scientific Advisory Board
Norman David Eansor 63 2018 Independent Chairman
Steven Arnote Elms 61 2019 Independent Director
James Patrick Allison - 2018 Member of Scientific Advisory Board
Cliona M. Rooney - 2018 Member of Scientific Advisory Board
John Robert Wilson 64 2018 Independent Director
Helen E. Heslop - 2018 Member of Scientific Advisory Board
Katharine Knobil 59 2021 Independent Director
Juan F. Vera 44 2018 Co-Founder, CEO, President, Treasurer, Secretary & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRKR Comments

Write your thoughts about Marker Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
OK GO
OK GO Jun 17, 2023 8:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
25% on no news?!
Anthony Morrow
Note7Creole Aug 07, 2022 3:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should see 🚀🚀's if we get that extension
Anthony Morrow
Note7Creole Aug 07, 2022 3:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ER 08/08 through 08/12
Hophop Recognize that
Dollarmachine Mar 25, 2021 11:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MRKR is strong, insiders holding the stock. Borrow fee is eating the lunch of the shortsellers.
Mohamed Shaibi
Mohamed Shaibi Mar 23, 2021 1:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not advise Buy order at 2.75
Hophop Recognize that
Dollarmachine Mar 22, 2021 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought in, extreme bullish.
Anthony Meunier
Anthony Meunier Mar 19, 2021 7:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im seeing alot of buying on this stock
Ab High
Ab High Mar 12, 2021 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.72
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email